AOD 9604 Capsules

Can specifically bind to β 3-adrenergic receptors on the membrane of adipocytes. This combination process is a key step in initiating fat decompose, just like inserting a key into a lock and opening the "door" to fat decompose. When it binds to the receptor, it triggers a series of complex signaling responses within adipocytes.

The combined signal transduction first leads to an increase in intracellular cyclic adenosine monophosphate (cAMP) levels. CAMP plays a crucial role as a second messenger in intracellular signaling. It is like a "messenger" inside the cell, transmitting external signals to the inside of the cell and activating protein kinase A (PKA). PKA is an important enzyme that can phosphorylate multiple target proteins, thereby regulating various physiological functions of cells. The activation of PKA is one of the key steps in the process of fat decompose.

Activated PKA phosphorylates and activates hormone sensitive lipase (HSL). HSL is a core enzyme in the process of fat decompose, which can catalyze the hydrolysis of triglycerides into glycerol and free fatty acids. Triglycerides are the main storage form of fat in adipocytes, and the role of HSL is like a "pair of scissors", cutting through triglyceride molecules and releasing glycerol and free fatty acids. Free fatty acids then enter the bloodstream and are taken up and utilized by other tisues, such as muscle tisue, which can use them as an energy source for oxidative decomposition, thereby reducing the accumulation of fat in adipocytes.

In animal experiments, injection into obese rats resulted in a significant increase in cAMP levels in their adipose tisue. This result indicates that it successfully activated the cAMP PKA signaling pathway. At the same time, the activity of HSL is significantly enhanced, and the rate of fat decompose is accelerated. Further observation revealed that the volume of adipocytes in rats significantly decreased, and their body weight also decreased accordingly. These experimental results fully demonstrate the effectiveness of AOD 9604 capsules in stimulating fat decompose.

Fatty acid synthase (FAS) is a key enzyme in the process of fat formation, catalyzing the synthesis of fatty acids from acetyl CoA and malonyl CoA, and subsequently synthesizing triglycerides. It can inhibit the expression and activity of FAS, reducing the synthesis of fatty acids from the source. This process is like closing the "factory gate" of fat synthesis, preventing the production of fatty acids and thus reducing the accumulation of fat in the body.

In cell experiments, adipocytes were co cultured with them. By detecting the mRNA expression level and enzyme activity of FAS in the cells, it was found that the expression and activity of FAS were significantly reduced. This indicates that it can directly act on adipocytes, inhibit the synthesis and function of FAS, and thus suppress the production of fatty acids.

Pre adipocytes are immature cells in adipose tisue that can differentiate into ripe adipocytes under certain conditions, increasing the number of adipocytes. It can regulate the expression of related genes and prevent the differentiation process of preadipocytes. It is like a "regulatory switch" that controls the fate of preadipocytes, preventing them from differentiating into ripe adipocytes and thus controlling the number of adipocytes.

Through cell culture experiments, pre adipocytes were co cultured with different concentrations of the substance for a period of time, and the proportion of pre adipocytes differentiating into ripe adipocytes was observed. The results showed that as the concentration increased, the proportion of preadipocytes differentiating into ripe adipocytes significantly decreased. This further demonstrates its role in inhibiting preadipocyte differentiation.

By inhibiting the expression and activity of FAS and the differentiation of preadipocytes, adipogenesis was suppressed from two aspects: fatty acid synthesis and an increase in the number of adipocytes. This dual inhibitory effect strictly regulates the process of fat generation in the body, reducing fat accumulation and providing an effective approach for obesity treatment.

Clinical studies have confirmed through normal glycemic index clamp technique that long-term use of it for treatment does not have adverse effects on animal insulin sensitivity. In the normal glycemic index clamp experiment, continuous infusion of insulin and glucose is used to maintain the animal's glycemic index levels within the normal range, while monitoring the metabolic clearance rate of insulin and the utilization rate of glucose.

The results showed that there was no significant difference in insulin sensitivity between animals treated with AOD 9604 capsules and the control group, and glycemic index levels remained stable. This indicates that while regulating fat metabolism, it can maintain the body's metabolic homeostasis without adversely affecting blood sugar and insulin sensitivity.

Metabolic homeostasis is an important mechanism for maintaining a constant internal environment in organisms and is crucial for the normal physiological functions of the body. When the flow rate of a metabolic pathway changes, it can lead to changes in the concentration of many metabolites.

Cells use certain regulatory mechanisms to counteract changes in metabolite concentration and maintain a stable state of metabolic kinetics. By precisely regulating fat metabolism, interference with other metabolic pathways is avoided, which helps maintain the body's metabolic homeostasis. For example, during the process of fat decompose, although the release of free fatty acids increases, it does not affect the utilization of glucose and insulin sensitivity in other tisues, allowing the body to maintain normal energy supply and metabolic function while losing weight.

Dietary control is one of the fundamental methods for shed pounds, achieved by reducing calorie intake. When combined with dietary control, it can further enhance the shed pounds effect. When dietary control is implemented, the body's energy supply decreases and the process of fat decompose is initiated to provide energy. It can stimulate the fat decompose signaling pathway, accelerate the decompose of fat, and enable the body to consume stored fat faster. At the same time, inhibiting fat production can prevent excessive storage of fat in the body due to reduced energy intake during dietary control, thereby better controlling weight.

For example, in a clinical trial, obese patients were divided into two groups, one group only received dietary control, and the other group received treatment based on dietary control. After a period of treatment, it was found that patients in the AOD 9604 group had a significantly greater shed pounds than those in the diet control group alone, and their fat mass decreased more while their muscle mass remained relatively stable. This indicates that AOD 9604 has a synergistic effect with dietary control and can improve shed pounds outcomes.

Exercise is another effective shed pounds method that can increase energy expenditure, promote fat decompose, and muscle growth. When combined with exercise, it can further optimize the shed pounds effect. Exercise can activate the sympathetic nervous system of the body, releasing hormones such as adrenaline, which can also bind to beta adrenergic receptors on the membrane of adipocytes, activating the lipolysis signaling pathway. When combined with exercise, it can enhance the activation of β 3-adrenergic receptors, making fat decompose more efficient.

In addition, exercise can promote muscle growth and repair, and to some extent, help increase muscle mass. The synergistic effect of the two can improve the muscle fat ratio of the body, increase the basal metabolic rate, and enable the body to consume more energy even in a resting state, thereby achieving long-term stable shed pounds effects. For example, in animal experiments, obese rats were injected with AOD 9604 while undergoing exercise training, and it was found that the effects of shed pounds, fat mass reduction, and muscle mass increase in rats were superior to those of rats that only underwent exercise training or were injected with AOD 9604 capsules.